Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
5,916,212
-
Shares change
-
-740,029
-
Total reported value, excl. options
-
$47,919,000
-
Value change
-
-$12,229,786
-
Put/Call ratio
-
91%
-
Number of buys
-
39
-
Number of sells
-
-23
-
Price
-
$8.1
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q4 2021
81 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q4 2021.
PDS Biotechnology Corp - Common (PDSB) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,916,212 shares
of 49,594,356 outstanding shares and own 11.93% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,014,860 shares), TWO SIGMA ADVISERS, LP (526,900 shares), TWO SIGMA INVESTMENTS, LP (482,166 shares), RENAISSANCE TECHNOLOGIES LLC (444,737 shares), BlackRock Inc. (431,405 shares), AIGH Capital Management LLC (308,034 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (297,300 shares), FIRST MANHATTAN CO (271,576 shares), INSPIRION WEALTH ADVISORS, LLC (246,440 shares), and GEODE CAPITAL MANAGEMENT, LLC (208,117 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.